ID23013A - Bahan-bahan farmakologi - Google Patents

Bahan-bahan farmakologi

Info

Publication number
ID23013A
ID23013A IDW991132A ID991132A ID23013A ID 23013 A ID23013 A ID 23013A ID W991132 A IDW991132 A ID W991132A ID 991132 A ID991132 A ID 991132A ID 23013 A ID23013 A ID 23013A
Authority
ID
Indonesia
Prior art keywords
pharmacological ingredients
pharmacological
ingredients
Prior art date
Application number
IDW991132A
Other languages
English (en)
Indonesian (id)
Inventor
David Nmn Bleakman
David Reed Helton
Smriti Iyengar
David Nmn Lodge
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID23013A publication Critical patent/ID23013A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW991132A 1997-04-07 1998-04-06 Bahan-bahan farmakologi ID23013A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4279597P 1997-04-07 1997-04-07

Publications (1)

Publication Number Publication Date
ID23013A true ID23013A (id) 1999-12-30

Family

ID=21923795

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991132A ID23013A (id) 1997-04-07 1998-04-06 Bahan-bahan farmakologi

Country Status (17)

Country Link
US (1) US6242462B1 (pt)
EP (1) EP0980358A4 (pt)
JP (1) JP2001521505A (pt)
KR (1) KR20010006075A (pt)
CN (1) CN1259126A (pt)
AU (1) AU734657B2 (pt)
BR (1) BR9809071A (pt)
CA (1) CA2285192A1 (pt)
EA (1) EA199900912A1 (pt)
HU (1) HUP0002030A3 (pt)
ID (1) ID23013A (pt)
IL (1) IL132086A0 (pt)
NO (1) NO994850L (pt)
NZ (1) NZ337827A (pt)
PL (1) PL336068A1 (pt)
TR (1) TR199902449T2 (pt)
WO (1) WO1998045270A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60002733T2 (de) * 1999-07-06 2004-03-18 Eli Lilly And Co., Indianapolis Diester prodrugs von decahydroischinoline-3-carbonsäure
BR0012175A (pt) 1999-07-06 2002-03-05 Lilly Co Eli Antagonistas de receptor de igiur5, seletivos para o tratamento de enxaqueca
AU2574801A (en) 1999-12-22 2001-07-03 Eli Lilly And Company Selective iGLUR5 receptor antagonists
US7205313B2 (en) 2001-01-05 2007-04-17 Eli Lilly And Company Excitatory amino acid receptor antagonists
US6924294B2 (en) 2001-01-05 2005-08-02 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU2002241565A1 (en) * 2001-01-05 2002-07-16 Eli Lilly And Company Excitatory amino acid receptor antagonist and 5-ht1f agonist combination: a method for the treatment of neurological disorders
US6953805B2 (en) 2001-01-05 2005-10-11 Eli Lilly And Company Excitatory amino acid receptor antagonists
JP4132049B2 (ja) * 2001-01-05 2008-08-13 イーライ リリー アンド カンパニー 興奮性アミノ酸レセプターアンタゴニスト
AU2002228736A1 (en) 2001-01-05 2002-07-16 Eli Lilly And Company Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
EP1355640A1 (en) 2001-01-23 2003-10-29 Neurosearch A/S Use of non-competitive and selective glur5 antagonists as glutamate receptor modulating compounds
DK1511741T3 (da) 2002-04-26 2013-01-21 Lilly Co Eli Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika
US20050101597A1 (en) * 2003-07-10 2005-05-12 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damage
US7795266B2 (en) * 2003-09-25 2010-09-14 Helton David R Tetrahydroindolone derivatives for treament of neurological conditions
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
JP2010510314A (ja) 2006-11-22 2010-04-02 シーサイド セラピューティクス,エルエルシー 精神遅滞、ダウン症候群、脆弱x症候群および自閉症の治療方法
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
WO2009062134A1 (en) * 2007-11-09 2009-05-14 Cenomed Biosciences, Llc Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
US20130058915A1 (en) 2010-03-02 2013-03-07 Children's Medica Center Corporation Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
US20110294879A1 (en) 2010-05-28 2011-12-01 Xenoport, Inc. Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
US20120016021A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
KR101746944B1 (ko) * 2015-09-23 2017-06-14 주식회사 포스코 도장 선영성이 우수한 도금강판의 제조방법 및 이에 의해 제조된 도금강판

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5446051A (en) 1994-05-31 1995-08-29 Eli Lilly And Company Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
CA2216648A1 (en) * 1995-02-15 1996-08-22 Bearsden Bio, Inc. Alkylcarboxy amino acids-modulators of the kainate receptor

Also Published As

Publication number Publication date
BR9809071A (pt) 2000-08-01
NO994850D0 (no) 1999-10-05
EA199900912A1 (ru) 2000-04-24
CN1259126A (zh) 2000-07-05
TR199902449T2 (xx) 2000-07-21
NZ337827A (en) 2000-12-22
KR20010006075A (ko) 2001-01-15
WO1998045270A1 (en) 1998-10-15
US6242462B1 (en) 2001-06-05
IL132086A0 (en) 2001-03-19
AU6955598A (en) 1998-10-30
PL336068A1 (en) 2000-06-05
AU734657B2 (en) 2001-06-21
CA2285192A1 (en) 1998-10-15
EP0980358A4 (en) 2001-02-07
NO994850L (no) 1999-10-05
HUP0002030A3 (en) 2002-01-28
EP0980358A1 (en) 2000-02-23
HUP0002030A2 (hu) 2001-04-28
JP2001521505A (ja) 2001-11-06

Similar Documents

Publication Publication Date Title
ATA93198A (de) Fluoxetinpellets
ID23013A (id) Bahan-bahan farmakologi
ATA111897A (de) Kimme
NO20002555L (no) Skjøt
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE69720185D1 (de) Verdunsterkarussell
ID24110A (id) Pembuatan rutenium kompleks
ID20403A (id) PEMBUATAN α-TOKOFEROL
ID20897A (id) Susunan penutup-rapat
FI970798A0 (fi) List foer en avvattningsanordning i en pappersmaskin
DE69838302D1 (de) Gruppenlaufzeitentzerrer
ID23663A (id) Persiapan kaprolaktam
FI972138A0 (fi) Returtraog i bestrykningsanordning
ATA86797A (de) Verschleissschuh
ATA46498A (de) Kunststoffgleitbahn
FI972751A (fi) Ääntä hajottava soladiffusorirakenne
ITDP970013A1 (it) Ruota singola - attrezzo sportivo - cicloidi
ATA159297A (de) Immuntolerante prothrombinkomplex-präparation
FI971698A0 (fi) Klingstyrenhet i en cirkelsaog
FI972997A0 (fi) Anordning i en sugsamlarvagn
FI972640A0 (fi) Gapformare i en pappersmaskin/kartongmaskin
FI971651A0 (fi) Spaormaskin i en elmaskin
FI971123A0 (fi) Foervarings- och transportredskap i synnerhet foer pappersprodukter
FI972891A0 (fi) I en vaeggkonstruktion infaellbart faerdigt elkanalnaet